The U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to reinstate a jury verdict it won against rivals Regeneron Pharmaceuticals Incand Sanofi SAin patent dispute over cholesterol medication.
from Reuters: Health News https://reut.rs/2VCOEUz
via
IFTTT
0 comments:
Post a Comment